Seeking Alpha
Recommended for you:
Profile| Send Message|
( followers)  

Pfizer (NYSE:PFE) is expected to report Q2 earnings on Tuesday, August 2 before the market open with a conference call scheduled for 10:00 am ET.

Guidance

Analysts are looking for EPS of 59c on revenue of $16.98B. The consensus range is 56c-65c for EPS, and $16.43B-$17.54B for revenue, according to First Call. On its Q1 earnings release, the drug giant gave FY11 EPS guidance of $2.16-$2.26. Positive catalysts may be seen coming from sales of Enbrel and Prevnar as well as from Wyeth and King synergies. Those positives may however be off-set by continued generic erosion, especially in Lipitor and Effexor.

Analyst Views

On July 18, Ticonderoga said it would be an aggressive buyer of Pfizer, based on catalysts from its August 2 pipeline update. The firm rates the shares a buy with a $20 price target.

Source: Earnings Preview: Pfizer